BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 30529090)

  • 1. Antiviral activity of brincidofovir on parvovirus B19.
    Bua G; Conti I; Manaresi E; Sethna P; Foster S; Bonvicini F; Gallinella G
    Antiviral Res; 2019 Feb; 162():22-29. PubMed ID: 30529090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral effect of cidofovir on parvovirus B19 replication.
    Bonvicini F; Bua G; Manaresi E; Gallinella G
    Antiviral Res; 2015 Jan; 113():11-8. PubMed ID: 25446336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced inhibition of parvovirus B19 replication by cidofovir in extendedly exposed erythroid progenitor cells.
    Bonvicini F; Bua G; Manaresi E; Gallinella G
    Virus Res; 2016 Jul; 220():47-51. PubMed ID: 27071853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroxyurea inhibits parvovirus B19 replication in erythroid progenitor cells.
    Bonvicini F; Bua G; Conti I; Manaresi E; Gallinella G
    Biochem Pharmacol; 2017 Jul; 136():32-39. PubMed ID: 28377277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-Throughput Screening Identifies Inhibitors for Parvovirus B19 Infection of Human Erythroid Progenitors.
    Ning K; Roy A; Cheng F; Xu P; Kleiboeker S; Escalante CR; Wang J; Qiu J
    J Virol; 2022 Jan; 96(2):e0132621. PubMed ID: 34669461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of 3-(Imidazo[2,1-
    Conti I; Morigi R; Locatelli A; Rambaldi M; Bua G; Gallinella G; Leoni A
    Molecules; 2019 Mar; 24(6):. PubMed ID: 30875983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endonuclease Activity Inhibition of the NS1 Protein of Parvovirus B19 as a Novel Target for Antiviral Drug Development.
    Xu P; Ganaie SS; Wang X; Wang Z; Kleiboeker S; Horton NC; Heier RF; Meyers MJ; Tavis JE; Qiu J
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30530599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The lipid moiety of brincidofovir is required for in vitro antiviral activity against Ebola virus.
    McMullan LK; Flint M; Dyall J; AlbariƱo C; Olinger GG; Foster S; Sethna P; Hensley LE; Nichol ST; Lanier ER; Spiropoulou CF
    Antiviral Res; 2016 Jan; 125():71-8. PubMed ID: 26526586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ex vivo-generated CD36+ erythroid progenitors are highly permissive to human parvovirus B19 replication.
    Wong S; Zhi N; Filippone C; Keyvanfar K; Kajigaya S; Brown KE; Young NS
    J Virol; 2008 Mar; 82(5):2470-6. PubMed ID: 18160440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cidofovir Diphosphate Inhibits Adenovirus 5 DNA Polymerase via both Nonobligate Chain Termination and Direct Inhibition, and Polymerase Mutations Confer Cidofovir Resistance on Intact Virus.
    Chamberlain JM; Sortino K; Sethna P; Bae A; Lanier R; Bambara RA; Dewhurst S
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30397065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in the Development of Antiviral Strategies against Parvovirus B19.
    Manaresi E; Gallinella G
    Viruses; 2019 Jul; 11(7):. PubMed ID: 31323869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No G-Quadruplex Structures in the DNA of Parvovirus B19: Experimental Evidence versus Bioinformatic Predictions.
    Bua G; Tedesco D; Conti I; Reggiani A; Bartolini M; Gallinella G
    Viruses; 2020 Aug; 12(9):. PubMed ID: 32854437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Parvovirus B19 Utilizes Cellular DNA Replication Machinery for Viral DNA Replication.
    Zou W; Wang Z; Xiong M; Chen AY; Xu P; Ganaie SS; Badawi Y; Kleiboeker S; Nishimune H; Ye SQ; Qiu J
    J Virol; 2018 Mar; 92(5):. PubMed ID: 29237843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of erythropoietin receptor signaling in parvovirus B19 replication in human erythroid progenitor cells.
    Chen AY; Guan W; Lou S; Liu Z; Kleiboeker S; Qiu J
    J Virol; 2010 Dec; 84(23):12385-96. PubMed ID: 20861249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent Advances in Replication and Infection of Human Parvovirus B19.
    Ganaie SS; Qiu J
    Front Cell Infect Microbiol; 2018; 8():166. PubMed ID: 29922597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human parvovirus B19 infection causes cell cycle arrest of human erythroid progenitors at late S phase that favors viral DNA replication.
    Luo Y; Kleiboeker S; Deng X; Qiu J
    J Virol; 2013 Dec; 87(23):12766-75. PubMed ID: 24049177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative activities of lipid esters of cidofovir and cyclic cidofovir against replication of herpesviruses in vitro.
    Williams-Aziz SL; Hartline CB; Harden EA; Daily SL; Prichard MN; Kushner NL; Beadle JR; Wan WB; Hostetler KY; Kern ER
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3724-33. PubMed ID: 16127046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parvovirus B19 Replication and Expression in Differentiating Erythroid Progenitor Cells.
    Bua G; Manaresi E; Bonvicini F; Gallinella G
    PLoS One; 2016; 11(2):e0148547. PubMed ID: 26845771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired genome encapsidation restricts the in vitro propagation of human parvovirus B19.
    Wolfisberg R; Ruprecht N; Kempf C; Ros C
    J Virol Methods; 2013 Oct; 193(1):215-25. PubMed ID: 23764418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A flow-FISH assay for the quantitative analysis of parvovirus B19 infected cells.
    Manaresi E; Bua G; Bonvicini F; Gallinella G
    J Virol Methods; 2015 Oct; 223():50-4. PubMed ID: 26231787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.